Valuation: Allurion Technologies Inc.

Capitalization 12M 10.24M 9.39M 8.89M 16.47M 1.15B 16.63M 112M 43.55M 545M 45.04M 44.09M 1.89B P/E ratio 2026 *
-0.59x
P/E ratio 2027 * -
Enterprise value 12M 10.24M 9.39M 8.89M 16.47M 1.15B 16.63M 112M 43.55M 545M 45.04M 44.09M 1.89B EV / Sales 2026 *
0.8x
EV / Sales 2027 * 0.5x
Free-Float
2.24%
Yield 2026 *
-
Yield 2027 * -
1 day+12.76%
1 week+16.35%
Current month+18.63%
1 month-3.67%
3 months-24.54%
6 months-46.67%
Current year-34.97%
1 week 0.65
Extreme 0.65
0.8
1 month 0.62
Extreme 0.62
0.95
Current year 0.23
Extreme 0.23
2.07
1 year 0.23
Extreme 0.23
3.42
3 years 0.23
Extreme 0.23
225
5 years 0.23
Extreme 0.23
225
10 years 0.23
Extreme 0.23
225
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 66 31/10/2017
Chief Executive Officer 40 31/08/2009
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 40 31/08/2009
Chairman 71 31/07/2023
Director/Board Member 39 31/12/2016
Change 5d. change 1-year change 3-years change Capi.($)
+12.76%+16.35%-66.11%-99.56% 10.65M
-1.18%-0.88%-9.24%+31.98% 3,065B
-0.65%+0.07%+14.81%+1,331.58% 328B
+6.49%+12.00%+172.00%+871.34% 111B
-1.69%+1.25%+14.84%+77.99% 100B
-0.58%+2.13%+1.51%+39.14% 98.88B
+13.14%+13.66%-32.59%+13.27% 51.98B
+2.04%+1.29%-0.11%+80.42% 41.01B
-3.88%-5.63%+24.54%+61.66% 31.56B
-2.93%-1.43%+73.38%+320.64% 30.14B
Average +2.62%-0.44%+19.30%+272.85% 385.86B
Weighted average by Cap. +0.62%+0.10%-0.37%+170.78%

Financials

2026 *2027 *
Net sales 15.05M 12.84M 11.77M 11.14M 20.65M 1.44B 20.85M 140M 54.6M 683M 56.47M 55.28M 2.37B 23.9M 20.38M 18.7M 17.7M 32.8M 2.29B 33.11M 223M 86.71M 1.09B 89.68M 87.79M 3.77B
Net income - -
Net Debt - -
Logo Allurion Technologies Inc.
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
Employees
40
Date Price Change Volume
12/05/26 0.7999 $ +12.76% 5,990
11/05/26 0.7094 $ -9.04% 16,835
08/05/26 0.7799 $ +14.71% 21,644
07/05/26 0.6799 $ -0.01% 16,232
06/05/26 0.6800 $ -1.09% 18,068
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7999USD
Average target price
5.500USD
Spread / Average Target
+587.59%

Quarterly revenue - Rate of surprise